Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Tax Provisions: 2019-2023

Historic Tax Provisions for ADC Therapeutics (ADCT) over the last 5 years, with Sep 2023 value amounting to -$100,000.

  • ADC Therapeutics' Tax Provisions fell 114.06% to -$100,000 in Q3 2023 from the same period last year, while for Sep 2023 it was -$4.3 million, marking a year-over-year decrease of 252.35%. This contributed to the annual value of -$1,139 for FY2022, which is 105.30% down from last year.
  • Latest data reveals that ADC Therapeutics reported Tax Provisions of -$100,000 as of Q3 2023, which was up 97.78% from -$4.5 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Tax Provisions registered a high of $1.2 million during Q1 2022, and its lowest value of -$4.5 million during Q2 2023.
  • Its 3-year average for Tax Provisions is -$180,363, with a median of -$3,967 in 2022.
  • Within the past 5 years, the most significant YoY rise in ADC Therapeutics' Tax Provisions was 1,219.40% (2020), while the steepest drop was 98,947.62% (2020).
  • Over the past 5 years, ADC Therapeutics' Tax Provisions (Quarterly) stood at -$115 in 2019, then surged by 1,219.40% to $3,000 in 2020, then plummeted by 4,933.33% to $21,971 in 2021, then tumbled by 118.06% to -$3,967 in 2022, then tumbled by 114.06% to -$100,000 in 2023.
  • Its last three reported values are -$100,000 in Q3 2023, -$4.5 million for Q2 2023, and $262,000 during Q1 2023.